Home / 2018 / February / 03

Daily Archives: Feb 3, 2018




Feb. 3, 2018

This would be a good week to set aside extra time to read the newsletter. There is so much information that I almost thought about splitting it up into 2 weeks but our publisher, Steve Freed, wouldn’t let me. We begin by finishing up with Part 4 of our special …

Read More »

How To Overcome The Complexities of Treatment Decisions For Your Patients with Type 2 Diabetes

Part 4: Using Computers to Determine Type 2 Treatment: The first three articles in this series focused on what makes treating type 2 diabetes so difficult: the overwhelming number of medicines and combinations; finding effective treatments that work with our patients' insurance coverage and household budgets; and incorporating factors beyond glucose control, such as body weight, adherence, and side effects, into our decisions. In this installment, we discuss how those problems can be represented in ways that computers can understand.

Read More »

Are You Getting Enough “SPA” Time?

By Sheri R. Colberg: Exploring the Benefits of Spontaneous Physical Activity

You’ve probably heard about the recent reports revealing just how dangerous it is to be sedentary. Simply sitting for too long at one time is now a recognized health hazard that everyone should be aware of. But if you suffer from diabetes or prediabetes, a sedentary lifestyle is particularly dangerous. Getting regular exercise and movement is one of the most important things you can do to keep your blood glucose under control, maintain a healthy body weight, and reduce your risk of developing complications related to diabetes.

Read More »

Adding Basal Insulin Analogue Detemir

A 59-year-old patient who was diagnosed with type 2 diabetes five years ago presents to your clinic for an appointment. He has a history of hypertension and dyslipidemia, both currently well-controlled with medication. He has been taking metformin and a DPP-4 inhibitor. He tells you he is concerned about a sore on his foot that is taking a long time to heal. At today’s visit, his office A1C is 8.8%. After discussing his options, you decide to add basal insulin analogue detemir to his regimen. Compared to insulin NPH, what would you expect him to experience while taking detemir? A. Less weight gain B. More hypoglycemia C. More weight gain D. No weight gain or hypoglycemia difference Follow the link for the answer.

Read More »

Ken Fujioka Current Interview

Ken Fujioka is director of the Nutrition and Metabolic Research Center and the Center for Weight Management in La Jolla California at the Scripps Clinic. His time is divided equally between clinical research and clinical practice. Research includes diets, medications, bariatric surgery, medical devices, web based weight loss programs, and outcomes in obesity treatment.

Read More »